Pharming Group’s sNDA for Joenja receives Complete Response Letter from U.S. FDA

Pharming Group NV, a Dutch biotech company, issued a press release cautioning investors about the potential risks associated with forward-looking statements. The company emphasized the importance of considering various factors that could impact the accuracy of future projections.

Pharming Group NV warned investors that forward-looking statements are subject to uncertainties and risks that could result in actual events and circumstances deviating from the predicted outcomes. The company highlighted the need for investors to exercise caution when relying on such statements to make investment decisions.

Pharming Group NV emphasized the unpredictable nature of the pharmaceutical industry, which is characterized by regulatory hurdles, market fluctuations, and unforeseen challenges. The company stressed the necessity of conducting thorough research and analysis before basing investment decisions on forward-looking statements.

According to Pharming Group NV, it is essential for investors to be aware of the potential risks and uncertainties associated with forward-looking statements. The company urged investors to consider all available information and to consult with financial advisors before making any investment decisions based on future projections.

Pharming Group NV indicated that despite the best efforts of the company to provide accurate and reliable information, external factors beyond its control could impact the realization of projected outcomes. The company underscored the importance of maintaining a cautious and informed approach when interpreting forward-looking statements.

In conclusion, Pharming Group NV highlighted the need for investors to exercise diligence and discernment when evaluating forward-looking statements. The company advised investors to consider all relevant factors and to seek professional advice to mitigate risks associated with future projections in the ever-changing pharmaceutical industry.